XBiotech Inc.
XBIT
$3.28
$0.4013.89%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -126.71% | 31.90% | -48.78% | -162.11% | -44.71% |
| Total Depreciation and Amortization | 1.15% | 1.62% | 0.00% | -2.48% | -2.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 945.80% | -116.93% | 325.36% | 509.63% | 72.45% |
| Change in Net Operating Assets | -190.35% | -127.07% | 194.93% | 123.05% | -18.34% |
| Cash from Operations | -90.50% | -293.07% | -26.44% | -49.79% | -8.50% |
| Capital Expenditure | 26.96% | -924.24% | -201.44% | -4,150.00% | 12.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 26.96% | -100.55% | -201.44% | -4,150.00% | 97.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 1,180.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 1,180.00% | 442.86% | -- | -- |
| Foreign Exchange rate Adjustments | -397.10% | 145.79% | -539.68% | -19,675.00% | -63.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -381.60% | -109.20% | -37.57% | 121.07% | 33.54% |
